多种疾病模式和类风湿性关节炎疾病结果:来自多中心,前性队列的发现
Sarah Dutt1, Punyasha Roul1, Yangyuna Yang1
1VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.
Arthritis care & research
|July 3, 2023
概括
某些多病症模式,包括心理健康,药物滥用,心血管问题和慢性疼痛,与风湿性关节炎 (RA) 疾病严重程度增加和功能低下有关. 解决这些并发症可能会改善RA治疗结果.
科学领域:
- 类风湿病学 类风湿病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病.
- 多病症,多种慢性疾病的存在,在RA患者中很常见.
- 了解多病态模式对于管理RA疾病严重程度和功能状态至关重要.
研究的目的:
- 调查不同多病态模式与长期类风湿性关节炎疾病严重程度之间的关联.
- 为了确定特定的并发症组合是否会随着时间的推移影响RA疾病活动和功能结果.
主要方法:
- 使用退伍军人事务风湿关节炎注册表进行了一项队列研究.
- 根据行政数据,先前定义的多病态模式被应用.
- 疾病活动 (DAS28) 和功能状态 (MDHAQ) 被纵向评估长达5年.
- 概括估计方程模型被用于分析关联,调整混因素.
主要成果:
- 这项研究包括2956名参与者,主要是男性和白人,有着高吸烟史.
- 心理健康/药物滥用,心血管和慢性疼痛多病症模式与较高的DAS28和MDHAQ分数有显著的关联.
- 多重多重病态模式的存在与RA疾病活动增加和功能状况较差有很强的相关性,所有四种模式都显示出最高分数.
结论:
- 特定的多病态模式,包括心理健康/药物滥用,慢性疼痛和心血管疾病,与RA疾病活动和功能状况的恶化有关.
- 识别和管理这些并发症可能是实现类风湿性关节炎治疗目标的关键.
- 这些发现强调了整体方法对RA管理的重要性,考虑到患者的整体健康状况.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
01:11Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
01:21Rheumatic Heart Disease III: Medical Management
22
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
01:23Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
01:20Rheumatic Heart Disease IV: Nursing Management
23
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
23
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
175
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
175